logo

This website uses cookies to ensure you get the best experience on our website.

Read through our Privacy Policy to learn more.

 Go Back

Coherus BioSciences: Q4 Earnings Snapshot

By AP News - Mar 10, 2025, 04:50 PM ET
Last Updated - Mar 10, 2025, 04:50 PM EDT
Coherus BioSciences: Q4 Earnings Snapshot

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus BioSciences Inc. (CHRS) on Monday reported a loss of $50.7 million in its fourth quarter.

The Redwood City, California-based company said it had a loss of 44 cents per share. Losses, adjusted for non-recurring costs and stock option expense, came to 28 cents per share.

Sponsored

The drug developer posted revenue of $54.1 million in the period.

For the year, the company reported profit of $28.5 million, or 25 cents per share. Revenue was reported as $267 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS

Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250412